| Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries Y Hsia, BR Lee, A Versporten, Y Yang, J Bielicki, C Jackson, J Newland, ... The Lancet Global Health 7 (7), e861-e871, 2019 | 269 | 2019 |
| Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients W Zhao, V Elie, G Roussey, K Brochard, P Niaudet, V Leroy, C Loirat, ... Clinical Pharmacology & Therapeutics 86 (6), 609-618, 2009 | 192 | 2009 |
| Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring W Zhao, E Lopez, V Biran, X Durrmeyer, M Fakhoury, E Jacqz-Aigrain Archives of disease in childhood 98 (6), 449-453, 2013 | 131 | 2013 |
| Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for … L Schrier, A Hadjipanayis, T Stiris, RI Ross-Russell, A Valiulis, MA Turner, ... European Journal of Pediatrics, 1-9, 2020 | 122 | 2020 |
| External evaluation of population pharmacokinetic models of vancomycin in neonates: the transferability of published models to different clinical settings W Zhao, F Kaguelidou, V Biran, D Zhang, K Allegaert, EV Capparelli, ... British journal of clinical pharmacology 75 (4), 1068-1080, 2013 | 118 | 2013 |
| Evidence-based guideline for therapeutic drug monitoring of vancomycin: 2020 update by the division of therapeutic drug monitoring, Chinese pharmacological society N He, S Su, Z Ye, G Du, B He, D Li, Y Liu, K Yang, X Zhang, Y Zhang, ... Clinical Infectious Diseases 71 (Supplement_4), S363-S371, 2020 | 97 | 2020 |
| Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration E Jacqz-Aigrain, W Zhao, M Sharland, JN van den Anker Seminars in Fetal and Neonatal Medicine 18 (1), 28-34, 2013 | 88 | 2013 |
| Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease W Zhao, D Zhang, M Fakhoury, M Fahd, F Duquesne, T Storme, ... Antimicrobial agents and chemotherapy 58 (6), 3191-3199, 2014 | 84 | 2014 |
| Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey S Leroux, W Zhao, P Bétrémieux, P Pladys, E Saliba, E Jacqz-Aigrain Archives of disease in childhood 100 (4), 394-398, 2015 | 83 | 2015 |
| Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal‐transplant patients W Zhao, M Fakhoury, G Deschênes, G Roussey, K Brochard, P Niaudet, ... The Journal of Clinical Pharmacology 50 (11), 1280-1291, 2010 | 77 | 2010 |
| Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients W Zhao, M Fakhoury, V Baudouin, T Storme, A Maisin, G Deschênes, ... European journal of clinical pharmacology 69, 189-195, 2013 | 72 | 2013 |
| Pharmacokinetic studies in neonates: the utility of an opportunistic sampling design S Leroux, MA Turner, CBL Guellec, H Hill, JN van den Anker, GL Kearns, ... Clinical pharmacokinetics 54, 1273-1285, 2015 | 71 | 2015 |
| Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age W Zhao, H Hill, C Le Guellec, T Neal, S Mahoney, S Paulus, C Castellan, ... Antimicrobial agents and chemotherapy 58 (11), 6572-6580, 2014 | 60 | 2014 |
| Clinical utility and safety of a model-based patient-tailored dose of vancomycin in neonates S Leroux, E Jacqz-Aigrain, V Biran, E Lopez, D Madeleneau, C Wallon, ... Antimicrobial agents and chemotherapy 60 (4), 2039-2042, 2016 | 59 | 2016 |
| Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease W Zhao, D Zhang, T Storme, A Baruchel, X Declèves, E Jacqz‐Aigrain British journal of clinical pharmacology 80 (5), 1197-1207, 2015 | 54 | 2015 |
| Paediatric drug development: are population models predictive of pharmacokinetics across paediatric populations? M Cella, W Zhao, E Jacqz‐Aigrain, D Burger, M Danhof, OD Pasqua British journal of clinical pharmacology 72 (3), 454-464, 2011 | 50 | 2011 |
| Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates V Ramos-Martín, A Johnson, J Livermore, L McEntee, J Goodwin, ... Journal of Antimicrobial Chemotherapy 71 (4), 992-1002, 2016 | 48 | 2016 |
| Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome W Zhao, V Elie, V Baudouin, A Bensman, JL André, K Brochard, F Broux, ... British journal of clinical pharmacology 69 (4), 358-366, 2010 | 46 | 2010 |
| Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants E Jacqz-Aigrain, S Leroux, AH Thomson, K Allegaert, EV Capparelli, ... Journal of Antimicrobial Chemotherapy 74 (8), 2128-2138, 2019 | 45 | 2019 |
| Choosing the right dose of tacrolimus P Lancia, E Jacqz-Aigrain, W Zhao Archives of disease in childhood 100 (4), 406-413, 2015 | 45 | 2015 |
